Media | Contact us
SEARCH:
Bavarian Nordic

Search

Your search saRNA monkey pox vaccin returned about 706 results:

Bavarian Nordic Enters Joint Procurement Agreement with the European Health Emergency Preparedness and Response Authority (HERA) for Monkeypox Vaccines

Bavarian Nordic Enters Joint Procurement Agreement with the European Health Emergency Preparedness and Response Authority (HERA) for Monkeypox Vaccines Two-year framework contract provides for up to 2 million doses of monkeypox vaccine for EU, EEA and Western Balkan countries Indication of initial demand of a total of approximately 700,000 doses for delivery in 2023 COPENHAGEN, Denmark, November...

Bavarian Nordic Enters Joint Procurement Agreement with the European Health Emergency Preparedness and Response Authority (HERA) for Monkeypox Vaccines

Bavarian Nordic Enters Joint Procurement Agreement with the European Health Emergency Preparedness and Response Authority (HERA) for Monkeypox Vaccines Two-year framework contract provides for up to 2 million doses of monkeypox vaccine for EU, EEA and Western Balkan countries Indication of initial demand of a total of approximately 700,000 doses for delivery in 2023 COPENHAGEN, Denmark, November...

Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for the Supply of Smallpox and Monkeypox Vaccine to Canada

Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for the Supply of Smallpox and Monkeypox Vaccine to Canada New contract amendment with Public Health Agency of Canada for the supply of IMVAMUNE valued at USD 234 million, with additional options spanning 10 years valued at USD 180 million Under the new contract amendment, the majority of the confirmed order will be ...

Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for the Supply of Smallpox and Monkeypox Vaccine to Canada

Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for the Supply of Smallpox and Monkeypox Vaccine to Canada New contract amendment with Public Health Agency of Canada for the supply of IMVAMUNE valued at USD 234 million, with additional options spanning 10 years valued at USD 180 million Under the new contract amendment, the majority of the confirmed order will be ...

Bavarian Nordic Enters Additional Monkeypox Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA)

Bavarian Nordic Enters Additional Monkeypox Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) New contract will double the supply of monkeypox vaccines to HERA before year-end Company upgrades financial guidance for 2022 COPENHAGEN, Denmark, September 7, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the European Health Emergency ...

Bavarian Nordic Enters Additional Monkeypox Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA)

Bavarian Nordic Enters Additional Monkeypox Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) New contract will double the supply of monkeypox vaccines to HERA before year-end Company upgrades financial guidance for 2022 COPENHAGEN, Denmark, September 7, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the European Health Emergency ...

Bavarian Nordic Enters Additional Contract with APAC Country for Supply of Smallpox/Monkeypox Vaccine in 2023

Bavarian Nordic Enters Additional Contract with APAC Country for Supply of Smallpox/Monkeypox Vaccine in 2023 Larger order for 2023 follows initial order for supply in 2022 COPENHAGEN, Denmark, August 3, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has entered a new contract with an undisclosed APAC country for the supply of 350,000 doses of its non-replicating JYNNEOS® smallp...

Bavarian Nordic Enters Additional Contract with APAC Country for Supply of Smallpox/Monkeypox Vaccine in 2023

Bavarian Nordic Enters Additional Contract with APAC Country for Supply of Smallpox/Monkeypox Vaccine in 2023 Larger order for 2023 follows initial order for supply in 2022 COPENHAGEN, Denmark, August 3, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has entered a new contract with an undisclosed APAC country for the supply of 350,000 doses of its non-replicating JYNNEOS® smallp...

Bavarian Nordic Receives Positive CHMP Opinion on the Extension of Vaccine Label to Include Monkeypox

Bavarian Nordic Receives Positive CHMP Opinion on the Extension of Vaccine Label to Include Monkeypox COPENHAGEN, Denmark, July 22, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that the marketing authorization for the Company’s smallpox vaccin...

Bavarian Nordic Receives Positive CHMP Opinion on the Extension of Vaccine Label to Include Monkeypox

Bavarian Nordic Receives Positive CHMP Opinion on the Extension of Vaccine Label to Include Monkeypox COPENHAGEN, Denmark, July 22, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that the marketing authorization for the Company’s smallpox vaccin...

Bavarian Nordic Secures Significant European Smallpox/Monkeypox Vaccine Order for 2023

Bavarian Nordic Secures Significant European Smallpox/Monkeypox Vaccine Order for 2023 Bavarian Nordic to supply an additional 1.5 million doses of IMVANEX® vaccine to an undisclosed European country Deliveries starting in the fourth quarter of 2022, but with the vast majority of doses to be delivered in 2023 COPENHAGEN, Denmark, July 19, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today t...

Bavarian Nordic Secures Significant European Smallpox/Monkeypox Vaccine Order for 2023

Bavarian Nordic Secures Significant European Smallpox/Monkeypox Vaccine Order for 2023 Bavarian Nordic to supply an additional 1.5 million doses of IMVANEX® vaccine to an undisclosed European country Deliveries starting in the fourth quarter of 2022, but with the vast majority of doses to be delivered in 2023 COPENHAGEN, Denmark, July 19, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today t...

Bavarian Nordic Enters Multiple Vaccine Contracts with Governments in Response to Global Monkeypox Outbreak

Bavarian Nordic Enters Multiple Vaccine Contracts with Governments in Response to Global Monkeypox Outbreak A number of contracts of varying size have been signed Deliveries to start immediately aiming to ensure a rapid response to the current monkeypox outbreak Company upgrades its financial guidance for 2022 COPENHAGEN, Denmark, July 18, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today t...

Bavarian Nordic Enters Multiple Vaccine Contracts with Governments in Response to Global Monkeypox Outbreak

Bavarian Nordic Enters Multiple Vaccine Contracts with Governments in Response to Global Monkeypox Outbreak A number of contracts of varying size have been signed Deliveries to start immediately aiming to ensure a rapid response to the current monkeypox outbreak Company upgrades its financial guidance for 2022 COPENHAGEN, Denmark, July 18, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today t...

U.S. Government Orders Another 2.5 Million Doses of Monkeypox Vaccines from Bavarian Nordic

U.S. Government Orders Another 2.5 Million Doses of Monkeypox Vaccines from Bavarian Nordic Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS® vaccine, bringing deliveries in 2022 and 2023 to a total of nearly 7 million doses Filling capacity is being expanded with a U.S. based contract manufacturer who will fill the vaccines using existing bulk vaccine from previous orders fr...

U.S. Government Orders Another 2.5 Million Doses of Monkeypox Vaccines from Bavarian Nordic

U.S. Government Orders Another 2.5 Million Doses of Monkeypox Vaccines from Bavarian Nordic Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS® vaccine, bringing deliveries in 2022 and 2023 to a total of nearly 7 million doses Filling capacity is being expanded with a U.S. based contract manufacturer who will fill the vaccines using existing bulk vaccine from previous orders fr...

U.S. Government Orders Additional Monkeypox Vaccines from Bavarian Nordic

U.S. Government Orders Additional Monkeypox Vaccines from Bavarian Nordic Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS® vaccine Doses will be manufactured using existing bulk vaccine from previous orders from BARDA Deliveries starting in the fourth quarter of 2022 with the majority to be delivered in 2023 COPENHAGEN, Denmark, July 1, 2022 – Bavarian Nordic A/S (OMX: BAVA...

U.S. Government Orders Additional Monkeypox Vaccines from Bavarian Nordic

U.S. Government Orders Additional Monkeypox Vaccines from Bavarian Nordic Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS® vaccine Doses will be manufactured using existing bulk vaccine from previous orders from BARDA Deliveries starting in the fourth quarter of 2022 with the majority to be delivered in 2023 COPENHAGEN, Denmark, July 1, 2022 – Bavarian Nordic A/S (OMX: BAVA...

Bavarian Nordic Enters Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) in Response to Monkeypox Outbreak

Bavarian Nordic Enters Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) in Response to Monkeypox Outbreak HERA has ordered 110,000 doses of the Company’s MVA-BN smallpox/monkeypox vaccine for donation to Member States Deliveries will start immediately and will be completed during the next months Company upgrades financial guidance for 2022 CO...

Bavarian Nordic Enters Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) in Response to Monkeypox Outbreak

Bavarian Nordic Enters Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority (HERA) in Response to Monkeypox Outbreak HERA has ordered 110,000 doses of the Company’s MVA-BN smallpox/monkeypox vaccine for donation to Member States Deliveries will start immediately and will be completed during the next months Company upgrades financial guidance for 2022 CO...

VIEW ALL